Showing results (291-300 of 384) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2017
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose LevelsPaolo G Casali, John Zalcberg, Axel Le Cesne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2021
Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumourSuzanne George, Ping Chi, Michael C Heinrich, et al.
JAMA Oncology|March 31, 2022
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical TrialRobin L Jones, Vinod Ravi, Andrew S Brohl, et al.
JAMA Oncology|September 10, 2020
Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical TrialSeth M Pollack, Mary W Redman, Kelsey K Baker, et al.
Molecular Cancer Therapeutics|November 12, 2020
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue SarcomaJavier Martín-Broto, Antonio López Pousa, Andrew S Brohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2021
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS StudySebastian Bauer, Michael C Heinrich, Suzanne George, et al.
Cancers|August 23, 2020
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 PandemicEugenie Younger, Alannah Smrke, Emma Lidington, et al.
Cancer Medicine|July 23, 2024
Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wallMadhumeeta Chadha, Sara Iadecola, Andrew Jenks, et al.
Cancers|July 2, 2021
The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)-A Protocol for an International Cohort StudyAnne-Rose W Schut, Milea J M Timbergen, Emma Lidington, et al.
Pageof 39